Description

According to a report by StrategyHelix, the global regenerative medicine market is set to increase by US$ 36.5 billion during 2022-2028, growing at a CAGR of 14.6% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for regenerative medicine. The global regenerative medicine market is segmented on the basis of product, application, end user, and region. On the basis of product, the global regenerative medicine market has been segmented into cell therapy, gene therapy, tissue engineering, others. By application, the global regenerative medicine market has been segmented into cardiovascular, dermatology, immunology, musculoskeletal, oncology, wound healing, others. Based on end user, the global regenerative medicine market is categorized into ambulatory service centers, hospitals, specialty centers, others. Geographically, the global regenerative medicine market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global regenerative medicine market is highly competitive. The prominent players operating in the global regenerative medicine market include Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Dendreon Pharmaceuticals LLC, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Integra LifeSciences Holdings Corporation, Mesoblast Limited, Novartis AG, Organogenesis Holdings Inc., Reliance Life Sciences Private Limited, Stryker Corporation, The Bristol-Myers Squibb Company, Vericel Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the regenerative medicine market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: cell therapy, gene therapy, tissue engineering, others
Application: cardiovascular, dermatology, immunology, musculoskeletal, oncology, wound healing, others
End user: ambulatory service centers, hospitals, specialty centers, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global regenerative medicine market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Regenerative medicine market overview
Part 3. Market breakdown by product
– Cell therapy
– Gene therapy
– Tissue engineering
– Others
Part 4. Market breakdown by application
– Cardiovascular
– Dermatology
– Immunology
– Musculoskeletal
– Oncology
– Wound healing
– Others
Part 5. Market breakdown by end user
– Ambulatory service centers
– Hospitals
– Specialty centers
– Others
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Amgen Inc.
– Astellas Pharma Inc.
– AstraZeneca plc
– Dendreon Pharmaceuticals LLC
– F. Hoffmann-La Roche AG
– Gilead Sciences, Inc.
– Integra LifeSciences Holdings Corporation
– Mesoblast Limited
– Novartis AG
– Organogenesis Holdings Inc.
– Reliance Life Sciences Private Limited
– Stryker Corporation
– The Bristol-Myers Squibb Company
– Vericel Corporation
About StrategyHelix
Disclaimer